Kamyar Afshar DO
Cystic Fibrosis, Interstitial Lung Diseases, Lung Transplantation Medicine, Restrictive Lung Disease
Clinical Professor of Medicine Medical Director, UC San Diego Lung Transplant Program
Join to view full profile
9300 Campus Point DriveLa Jolla, CA 92037
Phone+1 858-657-5050
Fax+1 858-657-7636
Dr. Afshar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kamyar Afshar is a pulmonologist based in La Jolla, CA, with subspecialties in cystic fibrosis, interstitial lung diseases, lung transplantation medicine, and restrictive lung disease. He completed his residency in internal medicine and fellowship in pulmonary disease and critical care medicine at the University of Southern California/Los Angeles General Medical Center. Since 2015, he has been practicing at UC San Diego Health. His expertise includes alpha-1 anti-trypsin deficiency, lung transplantation, and critical care medicine. Dr. Afshar has contributed to several publications in renowned journals related to lung transplantation and thoracic transplantation. In 2015, he received multiple CMS Meaningful Use Stage 1 Certifications from Cerner Corporation.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2002 - 2005
Arizona College of Osteopathic Medicine of Midwestern UniversityClass of 2002
Certifications & Licensure
CA State License 2004 - 2028
HI State License 2025 - 2028
NV State License 2025 - 2026
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2015
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2015
- CMS Meaningful Use Stage 1 Certification Powerchart, Cerner Healthe and Cerner Patient Portal, Cerner Corporation, 2015
Publications & Presentations
PubMed
- 1 citationsThe role of extracorporeal membrane oxygenation in the management of rapidly progressive interstitial lung disease due to anti-melanoma differentiation-associated gene...James M Jurica, Mazen F Odish, Christine M Lin, Robert L Owens, Cassia Yi
JHLT Open. 2026-05-01 - Belatacept in thoracic transplantation: Safety signals from lung recipients.Jade M Kozuch, Derek Chinn, Kamyar Afshar
The Journal of Heart and Lung Transplantation. 2026-05-01 - A rare case report of decompensated cirrhosis from hereditary hemochromatosis following lung transplant in a person with cystic fibrosis.Eunjeong Joo, Rebecca Golts, Harim Kang, Ajmera Veeral, Reice Robinson
Respiratory Medicine Case Reports. 2026-01-01
Press Mentions
COVID Y Los Pulmones: Los Trasplantes Son El Último Recurso Para Muchos Pacientes De CaliforniaOctober 14th, 2021- COVID Lungs: Transplants Are Last Resort for Many California PatientsOctober 13th, 2021
- Second Breath: Region's First Double Lung Transplant for COVID-19 PatientAugust 24th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
